戊型肝炎流行病学研究新进展

Preventive Medicine

2016, Vol. 28

Issue (10): 1014-1018 DOI:

Original Articles

Current Issue | Archive | Adv Search

Abstract
Figure/Table
References
Related Citation (15)

[1]陈小英, 许国章. 甲型和戊型病毒性肝炎的流行病学研究进展[J]. 浙江预防医学, 2014,26(9): 909-911.
[2]孙昼, 谢立, 祝绯飞, 等. 杭州市戊肝血清流行病学调查及流行特征分析[J]. 中国农村卫生事业管理, 2014, 31(1): 53-55.
[3]沈建勇, 韩建康, 金玫华, 等. 浙江省湖州市自然人群甲型及戊型肝炎IgG抗体平行检测结果分析[J]. 疾病监测,2007, 22(12): 809-811.
[4]仇家军, 喻荣彬. 戊型肝炎流行病学研究进展[J]. 中华疾病控制杂志,2009,13(5):572-576.
[5]PAVIO N, MENG X J, RENOU C. Zoonotic hepatitis E: animal reservoirs and emerging risks[J]. Vet Res, 2010, 41(6): 46.
[6]ZHAO C, MA Z, HARRISON T J, et al. A novel genotype of hepatitis E virus prevalent among farmed rabbits in China[J]. J Med Virol, 2009, 81(8): 1371-1379.
[7]BATTS W, YUN S, HEDRICK R, et al. A novel member of the family Hepeviridae from cutthroat trout (Oncorhynchus clarkii)[J]. Virus Res, 2011, 158(1-2): 116-123.
[8]DREXLER J F, SEELEN A, CORMAN V M, et al. Bats worldwide carry hepatitis E virus-related viruses that form a putative novel genus within the family Hepeviridae[J]. J Virol, 2012, 86(17): 9134-9147.
[9]BORGEN K, HERREMANS T, DUIZER E, et al. Non-travel related Hepatitis E virus genotype 3 infections in the Netherlands; a case series 2004-2006[J]. BMC Infect Dis, 2008, 8(1): 1-10.
[10]庄辉, 毕胜利, 王佑春, 等. 我国戊型肝炎研究[J]. 北京大学学报(医学版), 2002, 34(5): 434-439.
[11]FEAGINS A R, OPRIESSNIG T, GUENETTE D K, et al. Detection and characterization of infectious Hepatitis E virus from commercial pig livers sold in local grocery stores in the USA[J]. J Gen Virol, 2007, 88(Pt 3): 912-917.
[12]HEWITT P E, IJAZ S, BRAILSFORD S R, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England[J]. Lancet, 2014, 384(9956):1766-1773.
[13]SOMANI S K, AGGARWAL R, NAIK S R, et al. A serological study of intrafamilial spread from patients with sporadic hepatitis E virus infection[J]. J Viral Hepatitis, 2003, 10(6): 446-449.
[14]NAVANEETHAN U, AL MOHAJER M, SHATA M T. Hepatitis E and pregnancy: understanding the pathogenesis[J]. Liver Int, 2008, 28(9): 1190-1199.
[15]GU G, HUANG H, ZHANG L, et al. Hepatitis E virus seroprevalence in pregnant women in Jiangsu, China, and postpartum evolution during six years[J]. BMC Infect Dis, 2015, 15(1): 1-7.
[16]NIJSKENS C M, PAS S D, CORNELISSEN J, et al. Hepatitis E virus genotype 3 infection in a tertiary referral center in the Netherlands: Clinical relevance and impact on patient morbidity[J]. J Clin Virol, 2016(74): 82-87.
[17]GENG Y, ZHANG H, HUANG W, et al. Persistent hepatitis e virus genotype 4 infection in a child with acute lymphoblastic leukemia[J]. Hepat Mon, 2014, 14(1): e15618.
[18]SCHLOSSER B, STEIN A, NEUHAUS R, et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient[J]. J Hepatol, 2012, 56(2): 500-502.
[19]刘鹏, 王玲, 庄辉. 乙型肝炎病毒与戊型肝炎病毒重叠感染研究进展[J]. 中国病毒病杂志, 2011, 1(1): 71-74.
[20]商庆华, 于建国, 肖德明, 等. 慢性乙型肝炎患者重叠戊型肝炎病毒感染的临床与病理学研究[J]. 中华内科杂志, 2002,41(10):656-659.
[21]POLITOU M, BOTI S, ANDROUTSAKOS T, et al.Seroprevalence of hepatitis E in HIV infected patients in Greece[J]. J Med Virol, 2015, 87(9): 1517-1520.
[22]VISWANATHAN R. Infectious hepatitis in Delhi (1955-56): a critical study-epidemiology. 1957[J]. The Natl Med J India, 2013, 26(6): 362-377.
[23]PEREZ-GRACIA M T, SUAY B, MATEOS-LINDEMANN M L. Hepatitis E: an emerging disease[J]. Infect Genet Evol, 2014(22): 40-59.
[24]WHO. Hepatitis E.
[EB/OL](2014-06)[2015-12-30]. http://www.who.int/mediacentre/factsheets/fs280_jun2014/en/[25]KAMAR N, DALTON H R, ABRAVANEL F, et al. Hepatitis E virus infection[J]. Clin Microbiol Rev, 2014, 27(1): 116-138.
[26]付红伟, 朱永红, 庄辉. 我国戊型肝炎流行病学研究进展[J]. 中国病毒病杂志, 2011, 1(1): 67-70.
[27]GENG Y, ZHAO C, FAN J, et al. Genotype analysis of hepatitis E virus from sporadic hepatitis E cases in northern China[J].Infect Genet Evol, 2013(20): 413-417.
[28]ZHANG S, WANG J, YUAN Q, et al. Clinical characteristics and risk factors of sporadic Hepatitis E in central China[J]. Virol J, 2011, 8: 152.
[29]KMUSH B L, NELSON K E, LABRIQUE A B. Risk factors for hepatitis E virus infection and disease[J]. Expert Rev Anti Infect Ther, 2015, 13(1): 41-53.
[30]FIX A D, ABDEL-HAMID M, PURCELL R H, et al. Prevalence of antibodies to hepatitis E in two rural Egyptian communities[J]. Am J Trop Med Hyg, 2000, 62(4): 519-523.
[31]VAIDYA S R, TILEKAR B N, WALIMBE A M, et al. Increased risk of hepatitis E in sewage workers from India[J].J Occup Environ Med, 2003, 45(11): 1167-1170.
[32]KRUMBHOLZ A, MOHN U, LANGE J, et al. Prevalence of hepatitis E virus-specific antibodies in humans with occupational exposure to pigs[J]. Med Microbiol Immun, 2012, 201(2): 239-244.
[33]陈雪梅, 陈军. 江阴市食品及公共场所从业人员戊型肝炎感染调查[J]. 应用预防医学, 2014, 20(5): 308-310.
[34]姚晓芳, 徐佩华, 周晓红, 等. 海盐县食品和公共场所从业人员丙肝和戊肝感染的现状调查[J]. 浙江预防医学, 2013, 25(4): 51-58.
[35]普兴福. 昆明市2011年从业人员戊型肝炎病毒感染检测结果分析[J]. 中国卫生检验杂志, 2013, 23(11): 2512-2513.
[36]鲁波, 赵洪兰, 田瑞光, 等. 我国汉、回和藏族部分人群HEV感染的血清学调查[J]. 中华实验和临床病毒学杂志, 2012, 26(1): 46-47.
[37]夏宁邵, 张军, 李少伟, 等. 戊型病毒性肝炎研究进展[J]. 厦门大学学报(自然科学版), 2011, 50(2):431-436.
[38]ZHU F C, ZHANG J, ZHANG X F, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial[J]. Lancet, 2010, 376(9744): 895-902.
[39]SHRESTHA M P, SCOTT R M, JOSHI D M, et al. Safety and efficacy of a recombinant hepatitis E vaccine[J]. New Engl J Med, 2007, 356(9): 895-903.
[40]YANG S, WANG C, FANG X, et al. Fusion of C3d molecule with neutralization epitope(s) of hepatitis E virus enhances antibody avidity maturation and neutralizing activity following DNA immunization[J]. Virus Res, 2010, 151(2): 162-169.